StockNews.AI
TVTX
StockNews.AI
187 days

Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

1. Travere Therapeutics will report Q4 and full year 2024 financial results soon. 2. Financial results announcement scheduled for February 20, 2025, after market close. 3. A conference call will follow to discuss results and business updates.

3m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings reports often lead to stock volatility, but expectations are already priced in.

How important is it?

Earnings reports are crucial for future guidance, impacting investor expectations for TVTX.

Why Short Term?

Immediate effects anticipated around the earnings announcement based on investor sentiment.

Related Companies

TRVVRTXSAGENTLA
SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com. Contact Info

Related News